EVIFX
Price
$12.28
Change
+$0.08 (+0.66%)
Updated
Jun 26 closing price
Net Assets
1.02B
RLBCX
Price
$36.18
Change
+$0.26 (+0.72%)
Updated
Jun 26 closing price
Net Assets
247.64B
Interact to see
Advertisement

EVIFX vs RLBCX

Header iconEVIFX vs RLBCX Comparison
Open Charts EVIFX vs RLBCXBanner chart's image
Eaton Vance Balanced A
Price$12.28
Change+$0.08 (+0.66%)
VolumeN/A
Net Assets1.02B
American Funds American Balanced R3
Price$36.18
Change+$0.26 (+0.72%)
VolumeN/A
Net Assets247.64B
EVIFX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EVIFX vs. RLBCX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVIFX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 248B vs. EVIFX (1.02B). RLBCX pays higher dividends than EVIFX: RLBCX (1.63) vs EVIFX (1.23). EVIFX was incepted earlier than RLBCX: EVIFX (93 years) vs RLBCX (23 years). EVIFX (0.97) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. EVIFX (5.00). RLBCX has a lower initial minimum investment than EVIFX: RLBCX (250) vs EVIFX (1000). RLBCX annual gain was more profitable for investors over the last year : 7.01 vs. EVIFX (5.48). RLBCX return over 5 years is better than : 40.82 vs. EVIFX (33.68).
EVIFXRLBCXEVIFX / RLBCX
Total Expense Ratio0.970.89109%
Annual Report Gross Expense Ratio0.970.89109%
Fund Existence93 years23 years-
Gain YTD4.1706.56264%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B248B0%
Annual Yield % from dividends1.231.6375%
Returns for 1 year5.487.0178%
Returns for 3 years29.9531.5995%
Returns for 5 years33.6840.8283%
Returns for 10 years60.2260.7699%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRN31.150.50
+1.63%
Citi Trends
VRRM25.310.30
+1.20%
Verra Mobility Corp
NTLA9.610.05
+0.52%
Intellia Therapeutics
IT404.601.96
+0.49%
Gartner
GBIO0.36-0.01
-2.63%
Generation Bio Co